The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1662
ISSUE1662
October 31, 2022
Phosphodiesterase-5 Inhibitors for Alzheimer's Disease?
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Phosphodiesterase-5 Inhibitors for Alzheimer's Disease?
October 31, 2022 (Issue: 1662)
A reader asked us to review use of the
phosphodiesterase-5 (PDE5) inhibitor sildenafil for
treatment of Alzheimer's disease (AD).
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.